Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Spotlight on Saudi Arabia

    August 25, 2015 | Saudi Arabia, emerging markets 

    Published in eyeforpharma 20 May by Rachel Howard

    What are the opportunities and challenges for pharma companies wishing to gain a foothold in this oil-rich kingdom?

    Traditionally the Middle East and North Africa (MENA) region has been overlooked by pharmaceutical companies, with the region contributing only about 2% of global pharmaceutical sales in 2010. Difficult regulatory environments and political turmoil have compounded the perceived lack of attractiveness of the region as a whole.

    As we reach the middle of the decade, could the tide be turning? Over the last year, I have noticed increasing industry interest in Saudi Arabia (KSA) – and with good reason given it is the fastest growing pharmaceutical market in the Middle East, experiencing double-digit growth. In this article, I will take a look at the opportunities and challenges for pharma companies wishing to gain a foothold in this oil-rich kingdom.

    Background

    Though vast swathes of the country are uninhabitable desert, Saudi Arabia has a population fast approaching 30 million. It is a young country, with over half of the population under 30 years of age. As it is home to the holy Islamic cities of Mecca and Medina, its population receives a seasonal boost as over two million pilgrims visit each year to perform the Hajj. It also contains about a quarter of the world’s known petroleum reserves, and oil revenues account for approximately 90 percent of the government’s income.

    A key pillar of Saudi Arabia’s internal stability relative to much of the surrounding region has been the kingdom’s generous social welfare system, of which healthcare forms an important segment. Healthcare services are available free of charge not only to Saudi citizens but also to all pilgrims, regardless of their nationality. Recent decades have seen considerable improvement in both the quantity and quality of healthcare services. A Royal Decree in 2002 resulted in sizeable expansion of the primary care network. Care in the top public hospitals, such as Riyadh’s renowned King Fahad Medical City, easily rivals that of the West, with imported medical technology and state-of-the-art facilities. Medical education is also fully funded by the state, including overseas training. As a result, many physicians are trained in leading US and UK medical schools.

    However, not all is rosy. Despite the country’s affluence and stated commitment to healthcare, indicators suggest Saudi Arabia’s overall healthcare performance remains mediocre compared with the West, with an infant mortality rate that is double the average and a shorter life expectancy.

    Read the full article at http://www.researchpartnership.com/news/2015/05/spotlight-on-saudi-arabia/

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Eliminating Stigma: A consideration of the role the pharmaceutical industry can play

    My recent article in Medical Marketing & Media explored the importance of vaccine perceptions in a self-pay market and touched upon the issue of stigma, with the recognition that some diseases or...

    Fighting talk

    One thing that grasps my interest is how society has adopted military style language when talking about cancer

    Is MINT the next BRIC?

    In 2001, British economist Jim O’Neill coined the now ubiquitous acronym ‘BRIC’, to stand for the four emerging economies of Brazil, Russia, India and China, which he suggested were all...

    The healthcare market research themes for 2014

    As we shake off our winter coats and prepare for what will hopefully be a long, hot summer, the 2014 themes for healthcare and market research are emerging.

    Big Data—a new player in the Healthcare Industry

    Big Data is an exciting by-product of the information technology revolution and offers new ways of understanding customers.

    Blog: Affordable Care Act

    What does the future hold for the US pharma industry?

    Webinar: How to conduct effective market research in emerging markets

    Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge.

    Webinar: Uncovering hidden insights into patient compliance

    Pharma companies are increasingly looking for ways to provide “beyond the pill" services to support patients with the management of their disease. Adherence tools and programs encourage patients to stay compliant with their treatment...

    Webinar: The patient journey: Time to look beyond the physician?

    Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.

    Webinar: Ensuring an actionable segmentation

    One of the most consistent issues researchers face with segmentation is ensuring that it is actionable.